Can Early Stage Companies Still Finance Innovation?
BioWorld Insight Editor
SAN FRANCISCO – In the wake of President Obama making a brief fundraising stop here during his election campaign, center stage now falls to the more than 110 biotech execs who have gathered in the city to make their presentations to investors at the annual BIO Investor Forum (BIF).
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST